PeproStat

DRUG2 trials

Sponsors

Haemostatix Ltd

Conditions

BleedingHemorrhage

Phase 1

PeproStat Haemostat Study in Subjects Undergoing Liver Surgery

CompletedNCT02204930

Haemostatix LtdHemorrhage

Start: 2014-07-31End: 2015-09-30Updated: 2015-10-21

Phase 2

PeproStat as a Topical Agent Used to Stop Bleeding in Patients Undergoing Surgery

CompletedNCT03131336

Haemostatix LtdBleeding

Start: 2017-03-31End: 2017-10-11Updated: 2018-02-27